Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Genetic Signatures Limited

INVESTOR PRESENTATION - Genetic Signatures Limited

ASX:GSS

Genetic Signatures Limited

Health

Genetic Signatures Limited (GSS) is a molecular diagnostic (MDx) company operating in the global in vitro diagnostics (IVD) market. The Company designs and manufactures proprietary molecular diagnostic test solutions for rapid and specific identification of infectious diseases.

Read more

Market Cap

$281.46m

Price at Close

$1.97

4w avg. Volume

104.71k

4w avg. Turnover

$199.31k

Announcements
announcementt+2 movementdate
  • Supply agreement with major US customer

    Progress Report · Market sensitive

  • +0.99%

    23 Dec 2020

+0.99%

23 Dec 2020
  • Presenting at Bell potter healthcare conference

    Company Administration

  • -1.13%

    25 Nov 2020

-1.13%

25 Nov 2020
  • Ceasing to be a substantial holder

    Shareholder Details

  • +1.43%

    23 Nov 2020

+1.43%

23 Nov 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +1.43%

    23 Nov 2020

+1.43%

23 Nov 2020
  • Results of Meeting

    Notice Of Meeting

  • +1.14%

    20 Nov 2020

+1.14%

20 Nov 2020
  • AGM Chairman's address & CEO presentation

    Periodic Reports

  • +0.87%

    19 Nov 2020

+0.87%

19 Nov 2020
  • A$2.6m R&D rebate received

    Periodic Reports

  • -0.28%

    18 Nov 2020

-0.28%

18 Nov 2020
  • Appendix 2A

    Issued Capital

  • -0.28%

    18 Nov 2020

-0.28%

18 Nov 2020
  • Becoming a substantial holder

    Shareholder Details

  • -11.62%

    06 Nov 2020

-11.62%

06 Nov 2020
  • Ceasing to be a substantial holder

    Shareholder Details

  • -0.77%

    05 Nov 2020

-0.77%

05 Nov 2020
Market Data

Current Price

$1.97

52WK HIGH

$2.94

52WK LOW

$0.9

1YR RETURN

+97.00%

1YR RETURN VS. SECTOR

+59.49%

90 DAY RETURN

+5.07%

ASX RANK

527

/2,047

SECTOR RANK

39

/168

SHARES OUTSTANDING

142.87m
ASX:GSS

Genetic Signatures Limited

Health

Genetic Signatures Limited (GSS) is a molecular diagnostic (MDx) company operating in the global in vitro diagnostics (IVD) market. The Company designs and manufactures proprietary molecular diagnostic test solutions for rapid and specific identification of infectious diseases.

Read more

Market Cap

$281.46m

Price at Close

$1.97

4w avg. Volume

104.71k

4w avg. Turnover

$199.31k

ASX:GSS is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.